Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life
Ruth E. Uhlmann, Christine Rother, Jay Rasmussen, Juliane Schelle, Carina Bergmann, Emily M. Ullrich Gavilanes, Sarah K. Fritschi, Anika Buehler, Frank Baumann, Angelos Skodras, Rawaa Al‐Shaana, Natalie Beschörner, Lan Ye, Stephan A. Kaeser, Ulrike Obermüller, Søren Christensen, Fredrik Kartberg, Jeffrey B. Stavenhagen, Jens‐Ulrich Rahfeld, Holger Cynis, Fang Qian, Paul H. Weinreb, Thierry Bussière, Lary C. Walker, Matthias Staufenbiel, Mathias Jucker
Topics & Concepts
Genetically modified mouseTransgeneIn vivoAntibodyImmunoprecipitationAmyloid (mycology)Alzheimer's diseaseDiseaseAmyloid βPathologyBiologyAmyloid precursor proteinNeuroscienceMedicineCell biologyImmunologyGeneBiochemistryBiotechnologyAlzheimer's disease research and treatmentsPrion Diseases and Protein MisfoldingCholinesterase and Neurodegenerative Diseases